Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting Ali Akram, Derek Juang, Ranier Bustamante, Lin Liu, Ashley Earles, Samuel B. Ho, Jessica Wang-Rodriguez, James E. Allison, Samir Gupta Clinical Gastroenterology and Hepatology Volume 15, Issue 8, Pages 1265-1270.e1 (August 2017) DOI: 10.1016/j.cgh.2017.01.025 Copyright © 2017 AGA Institute Terms and Conditions
Supplementary Figure 1 Flowchart for individual test characteristics. Percentages reflect intention-to-screen outcomes, using number of tests ordered as denominator. FIT, fecal immunochemical test; gFOBT, guaiac fecal occult blood test; CRC, colorectal cancer. *CRC or advanced adenoma: adenoma >1 cm, villous or tubulovillous histology, and high-grade dysplasia. Clinical Gastroenterology and Hepatology 2017 15, 1265-1270.e1DOI: (10.1016/j.cgh.2017.01.025) Copyright © 2017 AGA Institute Terms and Conditions